Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Aids in determining menopausal status in individuals assigned female at birth, starting at 42 years of age. This test should be used in conjunction with other clinical and laboratory findings. For all other cases, refer to Anti-Mullerian Hormone (2002656).
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Serum separator tube. Also acceptable: Plain red or green (lithium heparin).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Separate from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP standard transport tube. (Min: 0.2 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Frozen.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-3 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Test Number
Components
Reference Interval
Anti-Mullerian Hormone, Menopause
Age
Reference Intervals (ng/mL)
40-45 years
Less than or equal to 6.282
46-50 years
Less than or equal to 0.064
Postmenopausal
Less than or equal to 0.003
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
MenoCheck is an FDA-cleared test intended to be used as an aid in the determination of menopausal status in people between 42 to 62 years of age that were assigned female at birth. This test should be used in conjunction with other clinical and laboratory findings. This test should not be used to assess a menstruating individual's fertility status or for use in monitoring or predicting the ovarian response in menstruating individuals undergoing or planning to undergo fertility treatments.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
AntiMullerian
Menocheck
Menochek
Menopause
MIF
MIH
MIS
Mullerian inhibiting factor
Mullerian-inhibiting hormone
Mullerian-inhibiting substance
Anti-Mullerian Hormone With Menopausal Status (MenoCheck)
Connect Sign In
